Fibroblast Growth Factor Homologous Factors in the Heart: A Potential Locus for Cardiac Arrhythmias

Trends in Cardiovascular Medicine

Volumn 21, Issue 7, 2011, Pages 199-203

  Wei, Eric Q ^a   Barnett, Adam S ^a   Pitt, Geoffrey S ^a   Hennessey, Jessica A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 11; FIBROBLAST GROWTH FACTOR 12; FIBROBLAST GROWTH FACTOR 13; FIBROBLAST GROWTH FACTOR 14; SODIUM CHANNEL NAV1.5; UNCLASSIFIED DRUG;

BRUGADA SYNDROME; HEART ARRHYTHMIA; HEART CONDUCTION; HEART MUSCLE CELL; LONG QT SYNDROME; LOSS OF FUNCTION MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SODIUM CURRENT;

ANIMALS; ARRHYTHMIAS, CARDIAC; DISEASE MODELS, ANIMAL; FIBROBLAST GROWTH FACTORS; HEART; MICE; MUTATION; MYOCYTES, CARDIAC; RATS; RISK FACTORS; VOLTAGE-GATED SODIUM CHANNELS;

EID: 84864573735     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.05.010     Document Type: Review

References (32)

1. Abriel H. Cardiac sodium channel Na(v)1.5 and interacting proteins: Physiology and pathophysiology. J Mol Cell Cardiol 2010, 48:2-11.
2. + channel activity through interactions between alpha- and beta1-subunits. Circ Res 1998, 83:141-146.
3. Antzelevitch C., Brugada P., Borggrefe M., et al. Brugada syndrome: Report of the second consensus conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005, 111:659-670.
4. Benhorin J., Goldmit M., MacCluer J.W., et al. Identification of a new SCN5A mutation, D1840G, associated with the long QT syndrome: Mutations in brief No153. Online. Hum Mutat 1998, 12:72.
5. Catterall W.A., Goldin A.L., Waxman S.G. International Union of Pharmacology: XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 2005, 57:397-409.
6. Fon Tacer K., Bookout A.L., Ding X., et al. Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol Endocrinol 2010, 24:2050-2064.
7. Gecz J., Baker E., Donnelly A., et al. Fibroblast growth factor homologous factor 2 (FHF2): Gene structure, expression and mapping to the Börjeson-Forssman-Lehmann syndrome region in Xq26 delineated by a duplication breakpoint in a BFLS-like patient. Hum Genet 1999, 104:56-63.
8. Goetz R., Dover K., Laezza F., et al. Crystal structure of a fibroblast growth factor homologous factor (FHF) defines a conserved surface on FHFs for binding and modulation of voltage-gated sodium channels. J Biol Chem 2009, 284:17883-17896.
9. Goldfarb M. Fibroblast growth factor homologous factors: Evolution, structure, and function. Cytokine Growth Factor Rev 2005, 16:215-220.
10. Hedley P.L., Jørgensen P., Schlamowitz S., et al. The genetic basis of Brugada syndrome: A mutation update. Hum Mutat 2009, 30:1256-1266.
11. + channels and impairs neuronal excitability. J Neurosci 2007, 27:12033-12044.
12. Lemaillet G., Walker B., Lambert S. Identification of a conserved ankyrin-binding motif in the family of sodium channel alpha subunits. J Biol Chem 2003, 278:27333-27339.
13. Liu C.J., Dib-Hajj S.D., Renganathan M., et al. Modulation of the cardiac sodium channel Nav15 by fibroblast growth factor homologous factor 1B. J Biol Chem 2003, 278:1029-1036.
14. Liu C.J., Dib-Hajj S.D., Waxman S.G. Fibroblast growth factor homologous factor 1B binds to the C terminus of the tetrodotoxin-resistant sodium channel rNav19a (NaN). J Biol Chem 2001, 276:18925-18933.
15. Lou J.Y., Laezza F., Gerber B.R., et al. Fibroblast growth factor 14 is an intracellular modulator of voltage-gated sodium channels. J Physiol 2005, 569:179-193.
16. Meadows L.S., Isom L.L. Sodium channels as macromolecular complexes: Implications for inherited arrhythmia syndromes. Cardiovasc Res 2005, 67:448-458.
17. Medeiros-Domingo A., Kaku T., Tester D.J., et al. SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome. Circulation 2007, 116:134-142.
18. Mohler P.J. Ankyrins and human disease: What the electrophysiologist should know. J Cardiovasc Electrophysiol 2006, 17:1153-1159.
19. Mohler P.J., Rivolta I., Napolitano C., et al. Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav15 on the surface of cardiomyocytes. Proc Natl Acad Sci U S A 2004, 101:17533-17538.
20. Munoz-Sanjuan I., Smallwood P.M., Nathans J. Isoform diversity among fibroblast growth factor homologous factors is generated by alternative promoter usage and differential splicing. J Biol Chem 2000, 275:2589-2597.
21. v1.5 in cardiomyocytes. Circ Res 2010, 108:294-304.
22. Rush A.M., Wittmack E.K., Tyrrell L., et al. Differential modulation of sodium channel Na(v)1.6 by two members of the fibroblast growth factor homologous factor 2 subfamily. Eur J Neurosci 2006, 23:2551-2562.
23. Sathaye A., Bursac N., Sheehy S., Tung L. Electrical pacing counteracts intrinsic shortening of action potential duration of neonatal rat ventricular cells in culture. J Mol Cell Cardiol 2006, 41:633-641.
24. Shakkottai V.G., Xiao M., Xu L., et al. FGF14 regulates the intrinsic excitability of cerebellar Purkinje neurons. Neurobiol Dis 2009, 33:81-88.
25. Smallwood P.M., Munoz-Sanjuan I., Tong P., et al. Fibroblast growth factor (FGF) homologous factors: New members of the FGF family implicated in nervous system development. Proc Natl Acad Sci USA 1996, 93:9850-9857.
26. Ueda K., Valdivia C., Medeiros-Domingo A., et al. Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex. Proc Natl Acad Sci U S A 2008, 105:9355-9360.
27. van Swieten J.C., Brusse E., de Graaf B.M., et al. A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia [corrected]. Am J Hum Genet 2003, 72:191-199.
28. Vatta M., Ackerman M.J., Ye B., et al. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 2006, 114:2104-2112.
29. Wang C., Chung B.C., Yan H., Lee S.Y., Pitt G.S. Crystal structure of the ternary complex of a NaV C-terminal domain, a fibroblast growth factor homologous factor, and calmodulin. Structure 2012, 20:1167-1176.
30. + channels and conduction velocity in murine hearts. Circ Res 2011, 109:775-782.
31. Wang C., Wang C., Hoch E.G., Pitt G.S. Identification of novel interaction sites that determine specificity between fibroblast growth factor homologous factors and voltage-gated sodium channels. J Biol Chem 2011, 286:24253-24263.
32. Wang Q., Shen J., Splawski I., et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995, 80:805-811.